Company

DoMore Diagnostics

Hospitals And Health Care Oslo, No 12 employees

Employees: 12
Contacts: 1
Emails: 1

domorediagnostics.com LinkedIn Crunchbase

DoMore Diagnostics Overview

Headquarters: Oslo, No
Website: domorediagnostics.com
Industry: Hospitals And Health Care
Employees: 12
Founded: 2021
NAICS: Health Care and Social Assistance

Social Assistance

Keywords

Cancer Artificial intelligence Deep learning Diagnostics Prognostication Precision Medicine

About DoMore Diagnostics

DoMore Diagnostics uses artificial intelligence to make personalized treatment decisions simple and accessible for all cancer patients. Its unique digital biomarkers predict patient outcomes from routine tumor tissue slides and can be seamlessly integrated into pathologists’ existing workflow. The lead product Histotype Px® Colorectal is a CE-IVDD marked outcome prediction marker for stage II and III colorectal adenocarcinoma that informs the decision of whether to provide adjuvant chemotherapy following surgical resection of the tumor. The company is based on prominent international research from leading universities and funded by top Norwegian tech investors.

DoMore Diagnostics Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

DoMore Diagnostics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Madeleine Xuyen Ho	Product Manager @ Domore Diagnostics - Product & Marketing Manager, Project Manager		View
Yvind Grotmol	Scientist at Wayve		View
Ketil F. Widerberg	General Manager	Oslo, Norway	Email
Torbjørn Furuseth	CEO and Co-founder		View